NovoCure Ltd.

( )
NVCR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. 1.41%558.281.0%$831.35m
MDTMedtronic Plc -0.23%76.900.6%$662.06m
DHRDanaher Corp. 0.98%267.950.7%$632.68m
ABTAbbott Laboratories 0.89%104.780.8%$525.73m
ABMDABIOMED, Inc. -0.04%377.793.3%$521.45m
ISRGIntuitive Surgical, Inc. 0.62%267.960.8%$490.52m
BDXBecton, Dickinson & Co. 0.86%246.481.0%$430.02m
EWEdwards Lifesciences Corp. 0.44%72.590.4%$405.39m
SYKStryker Corp. 2.77%242.071.3%$316.75m
DXCMDexCom, Inc. 0.92%117.911.9%$289.68m
BAXBaxter International, Inc. 1.65%52.361.8%$270.40m
BSXBoston Scientific Corp. 1.04%45.631.0%$252.86m
AAgilent Technologies, Inc. 1.59%153.751.7%$218.07m
WSTWest Pharmaceutical Services, Inc. 0.40%235.921.6%$184.74m
ALGNAlign Technology, Inc. 0.69%187.336.4%$176.48m

Company Profile

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.